Investor insights: Sharing control with investors #3

Investor insights: Sharing control with investors #3

Don’t ask, don’t get Here we are again on the fascinating subject of investor consents. We’ve previously scheduled out why investors want them, what they are, and now let’s take a look at when they get deployed in practice. As with a lot of venture investing rules,...
Investor insights: Sharing control with investors #2

Investor insights: Sharing control with investors #2

Why do investors need special rights? We covered off in our last post the typical rights that investors seek in the running of a scale-up company, and now ask the question: why do they need those rights in the first place? It helps for founders to understand the...
Investor insights: Sharing control with investors #1

Investor insights: Sharing control with investors #1

Learning to live with strangers We recently completed an investment in our seventh portfolio company. An exceptional business, great management, but nothing extraordinary about the deal. Except that, in this instance, we have never met any of the founders and...
4D Biomaterials completes GBP1.6m funding round led by DSW Ventures

4D Biomaterials completes GBP1.6m funding round led by DSW Ventures

A company which has developed a new type of biomaterial that can be used for 3D printing of medical implants has completed a £1.6m funding round.  The investment into Nottingham-based 4D Biomaterials was led by DSW Ventures and backed by the MEIF Proof of Concept...
Investor insights: Exit preference – fixing a bad legacy

Investor insights: Exit preference – fixing a bad legacy

Exit preference – yet more problems down the line   In our last post we covered what kind of follow-on round structures were likely to follow, when an earlier round contained exit preference rights.   In this post, let’s consider the position when that earlier-round...